Newsletter | September 15, 2026

09.15.26 -- A Simple Eye Drop For A Blinding Disease? Claris Bio Raises $118M And Prepares For Pivotal Trials

SPONSOR

 

Unlocking Challenging Targets with Macrocycle DNA-Encoded Libraries

What if the next breakthrough target requires more than a conventional small molecule? Explore how macrocycle DNA-encoded libraries are opening new paths to challenging drug targets. This X-CHEM webinar will reveal how macrocycles expand chemical space, uncover differentiated hits, and generate insights that can accelerate discovery. Learn where macrocycle DELs can make the biggest impact and how they could reshape your strategy. Click here to learn more.

FEATURED EDITORIAL

A Simple Eye Drop For A Blinding Disease? Claris Bio Raises $118M And Prepares For Pivotal Trials

CSB-001, Claris Bio’s eye drop for limbal stem cell deficiency, could offer a non-surgical way to improve vision, slow vision loss, and reshape LSCD care.

 

The Future Is Ancient: Evolution, Metabolics, And AI

We caught up with Hannah Gordon, Ph.D., chief scientific officer of Enveda, to discuss why the future may depend more on decoding nature’s evolutionarily selected chemistry.

The Next Chapter Of Obesity And Type 2 Diabetes Care: ADA 2026 Signals A More Personalized Future

The American Diabetes Association 2026 conference showed where we are and where we're going with GLP-1 therapies.

INDUSTRY INSIGHTS

 

Residual iPSC And Genomic Stability Testing With High Multiplex Digital PCR

Sensitive digital PCR methods enable confident detection of low‑abundance iPSC markers. Gain insight into how these capabilities support more reliable monitoring and quality assessment.

 

The Ultimate Guide To Stress-Free Pipetting

Improve accuracy and reduce stress with expert pipetting tips. Discover how technique and tool selection can boost precision and efficiency, ensuring consistent results across every lab workflow.

 

Sustainable Analytical Labs: Software For Greener Chromatography

Chromatography's environmental footprint is often overlooked. Applying green chemistry principles reduces solvent use and waste, unlocking sustainable workflows without losing performance.

 

Enabling Effective Passive And Active Immune Cell Targeting Strategies

Targeted LNPs that bypass the liver and home to the spleen could reshape in vivo CAR T cell manufacturing. See the data behind the approach.

 

Solid Form Screening Of Active Pharmaceutical Ingredients

Explore the role of solid form services in helping meet accelerated timelines of the drug development lifecycle along with examples of robust workflows for fast and thorough solid form screens.

SOLUTIONS

Hybridoma Services

Expand Your T-Cell Research With Confidence